Clarus Defined Exit I, L.p. - Net Worth and Insider Trading
Clarus Defined Exit I, L.p. Net Worth
The estimated net worth of Clarus Defined Exit I, L.p. is at least $1 Million dollars as of 2024-11-13. Clarus Defined Exit I, L.p. is the 10% Owner of Talaris Therapeutics Inc and owns about 503,577 shares of Talaris Therapeutics Inc (TALS) stock worth over $1 Million. Details can be seen in Clarus Defined Exit I, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Clarus Defined Exit I, L.p. has not made any transactions after 2021-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Clarus Defined Exit I, L.p.
Clarus Defined Exit I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clarus Defined Exit I, L.p. owns 1 companies in total, including Talaris Therapeutics Inc (TALS) .
Click here to see the complete history of Clarus Defined Exit I, L.p.’s form 4 insider trades.
Insider Ownership Summary of Clarus Defined Exit I, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TALS | Talaris Therapeutics Inc | 2021-05-11 | 10 percent owner |
Clarus Defined Exit I, L.p. Latest Holdings Summary
Clarus Defined Exit I, L.p. currently owns a total of 1 stock. Clarus Defined Exit I, L.p. owns 503,577 shares of Talaris Therapeutics Inc (TALS) as of May 11, 2021, with a value of $1 Million.
Latest Holdings of Clarus Defined Exit I, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TALS | Talaris Therapeutics Inc | 2021-05-11 | 503,577 | 2.72 | 1,369,729 |
Holding Weightings of Clarus Defined Exit I, L.p.
Clarus Defined Exit I, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Clarus Defined Exit I, L.p. has made a total of 1 transactions in Talaris Therapeutics Inc (TALS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Talaris Therapeutics Inc is the acquisition of 3,000 shares on May 11, 2021, which cost Clarus Defined Exit I, L.p. around $510,000.
Insider Trading History of Clarus Defined Exit I, L.p.
- 1
Clarus Defined Exit I, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Clarus Defined Exit I, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clarus Defined Exit I, L.p. is -0.35%. GuruFocus also compares Clarus Defined Exit I, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Clarus Defined Exit I, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clarus Defined Exit I, L.p.'s insider trading performs compared to the benchmark.
Performance of Clarus Defined Exit I, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.29 | | | | | |
| Relative Return to S&P 500(%) | 20.99 | | | | | |
Clarus Defined Exit I, L.p. Ownership Network
Ownership Network List of Clarus Defined Exit I, L.p.
Ownership Network Relation of Clarus Defined Exit I, L.p.
Clarus Defined Exit I, L.p. Owned Company Details
What does Talaris Therapeutics Inc do?
Who are the key executives at Talaris Therapeutics Inc?
Clarus Defined Exit I, L.p. is the 10 percent owner of Talaris Therapeutics Inc. Other key executives at Talaris Therapeutics Inc include Interim CFO Ryan F. Robinson , Chief Medical Officer Yung H. Chyung , and CBO & GC and Secretary W Bradford Middlekauff .
Talaris Therapeutics Inc (TALS) Insider Trades Summary
Over the past 18 months, Clarus Defined Exit I, L.p. made no insider transaction in Talaris Therapeutics Inc (TALS). Other recent insider transactions involving Talaris Therapeutics Inc (TALS) include a net sale of 218,472 shares made by Suzanne Ildstad ,
In summary, during the past 3 months, insiders sold 0 shares of Talaris Therapeutics Inc (TALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 21,847 shares of Talaris Therapeutics Inc (TALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,847 shares.
Talaris Therapeutics Inc (TALS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Talaris Therapeutics Inc Insider Transactions
Clarus Defined Exit I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Clarus Defined Exit I, L.p.. You might contact Clarus Defined Exit I, L.p. via mailing address: 101 Main Street, Suite 1210, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
